Clinical Trials Directory

Trials / Completed

CompletedNCT04019496

Neurophysiology of Prophylactic Treatment in Migraine

Neurophysiological Characterization of Treatment Response Following the Initiation of Prophylactic Therapy in Episodic Migraine

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
University Medicine Greifswald · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to improve the pathophysiological understanding of migraine in in a longitudinal observational study investigating changes of established neurophysiological and imaging parameters in line with changes of the clinical phenotype. The study's focus is the investigation of mechanisms that are directly related to the cyclic character of migraine and its core structures. In this context, the primary endpoint is a change in the nociceptive blink reflex, an established brain stem reflex to study the trigemino-spinal system, associated with changes in migraine frequency and severity. In order to reliably detect changes in the trigeminal pain system, investigations are performed in patients before starting a prophylactic therapy and 3 months afterwards. Several secondary endpoints are used to evaluate changes of multimodal sensory and cortical information processing. Cerebral imaging will include examinations of structural and network effects of altered migraine disease activity.

Conditions

Interventions

TypeNameDescription
DRUGantibodies against calcitonin-gene related peptide or its receptorthe study is observational and does not interfere with clinical routine. In lin with this notion, the intervention is chosen by the treating physician in a shared decision making process involving the patient

Timeline

Start date
2019-01-29
Primary completion
2021-05-02
Completion
2021-05-02
First posted
2019-07-15
Last updated
2021-05-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04019496. Inclusion in this directory is not an endorsement.